Trial intelligence / Profile preview

Artemether-lumefantrine efficacy surveillance for uncomplicated malaria in Laos

ACTRN12619000408189Phase 4Not yet recruiting

Sponsor
Ministry of Health
Start
Apr 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of artemether, lumefantrine and primaquine, sponsored by Ministry of Health. Planned start Apr 2020; status: not yet recruiting.

02

Drugs

artemetherlumefantrineprimaquine

Beyond the preview

Go deeper on ACTRN12619000408189.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12619000408189.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call